MarketCap
Facebook
X
Telegram
Prestige Consumer Healthcare Balance Sheet 2026-2009 | PBH
Brief overview of Prestige Consumer Healthcare 's financial position
Balance sheet changes are traced across five available annual reports between 2022 and 2026.
Assets changed little, standing at $3.7 billion initially and $3.5 billion at the end. The balance sheet stayed close to its former scale.
Liability growth of -23.2% trailed asset growth of -4.8%. The funding structure became more resilient.
The equity-to-assets ratio is 54%, compared with 43% five periods ago. The balance sheet has a substantial internal cushion.
Net debt to equity stands at 0.5x; the current burden does not look excessive.
Cash equals 1.8% of the balance sheet, compared with 0.7% five periods ago. This is the readily available cushion.
Retained earnings reached $1.7 billion, changing +43.8% over the period. A positive accumulated result supports equity.
Conclusion
Prestige Consumer Healthcare has a solid balance sheet cushion. Capital and liquidity support development without excessive reliance on debt.
Annual Balance Sheet Prestige Consumer Healthcare
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
937 M | 901 M | 1.08 B | 1.29 B | 1.46 B | 1.45 B | 1.67 B | 1.77 B | 1.96 B | 2.15 B | 1.6 B | 1.57 B | 906 M | 955 M | 1.1 B | 474 M | - | - |
Long Term Debt |
994 M | 992 M | 1.13 B | 1.35 B | 1.48 B | 1.48 B | 1.73 B | 1.8 B | 1.99 B | 2.19 B | 1.63 B | 1.59 B | 934 M | 971 M | 1.12 B | 487 M | - | - |
Long Term Debt Current |
6.91 M | 6.05 M | 4.66 M | 6.93 M | 6.36 M | 5.86 M | 5.61 M | 5.7 M | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | 2.19 B | 2.22 B | 2.46 B | 2.93 B | 2.1 B | 1.94 B | 1.15 B | 1.17 B | 1.29 B | 641 M | - | - |
Total Current Liabilities |
121 M | 107 M | 117 M | 161 M | 143 M | 122 M | 150 M | 127 M | 123 M | 162 M | 107 M | 99 M | 84.4 M | 96.7 M | 63.9 M | - | - | - |
Total Liabilities |
1.61 B | 1.57 B | 1.66 B | 1.91 B | 2.09 B | 2.07 B | 2.34 B | 2.35 B | 2.58 B | 3.09 B | 2.2 B | 2.04 B | 1.23 B | 1.26 B | 1.36 B | 695 M | - | - |
Retained Earnings |
1.75 B | 1.56 B | 1.34 B | 1.13 B | 1.21 B | 1.01 B | 844 M | 702 M | 736 M | 397 M | 327 M | 227 M | 149 M | 76.2 M | 10.7 M | -26.2 M | - | - |
Total Assets |
3.49 B | 3.4 B | 3.32 B | 3.35 B | 3.67 B | 3.43 B | 3.51 B | 3.44 B | 3.76 B | 3.91 B | 2.95 B | 2.67 B | 1.8 B | 1.74 B | 1.76 B | 1.06 B | - | - |
Cash and Cash Equivalents |
63.9 M | 97.9 M | 46.5 M | 58.5 M | 27.2 M | 32.3 M | 94.8 M | 27.5 M | 32.5 M | 41.9 M | 27.2 M | 21.3 M | 28.3 M | 15.7 M | 19 M | 13.3 M | 41.1 M | 35.2 M |
Book Value |
1.89 B | 1.83 B | 1.66 B | 1.45 B | 1.58 B | 1.36 B | 1.17 B | 1.1 B | 1.18 B | 823 M | 744 M | 628 M | 563 M | 478 M | 403 M | 362 M | - | - |
Total Shareholders Equity |
1.89 B | 1.83 B | 1.66 B | 1.45 B | 1.58 B | 1.36 B | 1.17 B | 1.1 B | 1.18 B | 823 M | 744 M | 628 M | 563 M | 478 M | 403 M | 362 M | 329 M | 294 M |
All numbers in USD currency
Quarterly Balance Sheet Prestige Consumer Healthcare
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
1.03 B | 993 M | 993 M | 1.03 B | 993 M | 993 M | 1.1 B | 1 B | 1.06 B | 1.1 B | 1.33 B | 1.21 B | 1.28 B | 1.33 B | 1.36 B | 1.44 B | 1.46 B | - | 1.5 B | 1.55 B | 1.61 B | 1.55 B | 1.48 B | 1.55 B | 1.55 B | 1.62 B | 1.73 B | 1.7 B | 1.75 B | 1.78 B | 1.8 B | 1.84 B | 1.9 B | 1.99 B | 1.99 B | 2.05 B | 2.09 B | 2.15 B | 2.19 B | 1.42 B | 1.48 B | 1.58 B | 1.63 B | 1.45 B | 1.47 B | 1.51 B | 1.56 B | 1.64 B | 1.69 B | 970 M | 934 M | 982 M | 979 M | 953 M | 971 M | 1 B | 1.08 B | 1.1 B | 1.12 B | 430 M | 447 M | 464 M | 487 M |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 358 K | - | 302 K | 296 K | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
1.67 B | 1.62 B | 1.58 B | 1.67 B | 1.62 B | 1.58 B | 1.63 B | 1.54 B | 1.59 B | 1.63 B | 1.87 B | 1.74 B | 1.8 B | 1.87 B | 1.91 B | 2.06 B | 2.06 B | - | 2.09 B | 2.14 B | 2.21 B | 2.14 B | 2.07 B | 2.15 B | 2.16 B | 2.22 B | 2.34 B | 2.31 B | 2.35 B | 2.36 B | 2.35 B | 2.43 B | 2.5 B | 2.61 B | 2.58 B | 2.68 B | 3.01 B | 3.04 B | 3.09 B | 2.01 B | 2.06 B | 2.14 B | 2.2 B | 1.92 B | 1.94 B | 1.97 B | 2.01 B | 2.07 B | 2.13 B | 1.27 B | 1.23 B | 1.32 B | 1.27 B | 1.24 B | 1.26 B | 1.27 B | 1.35 B | 1.33 B | 1.36 B | 644 M | 664 M | 671 M | 695 M |
Retained Earnings |
1.69 B | 1.65 B | 1.6 B | 1.69 B | 1.65 B | 1.6 B | 1.39 B | 1.51 B | 1.44 B | 1.39 B | 1.19 B | 1.29 B | 1.24 B | 1.19 B | 1.13 B | 1.37 B | 1.32 B | - | 1.21 B | 1.16 B | 1.11 B | 1.07 B | 1.01 B | 973 M | 932 M | 888 M | 844 M | 807 M | 769 M | 736 M | 702 M | 841 M | 803 M | 772 M | 736 M | 776 M | 461 M | 430 M | 397 M | 386 M | 354 M | 322 M | 327 M | 313 M | 285 M | 254 M | 227 M | 204 M | 182 M | 166 M | 149 M | 133 M | 130 M | 96.9 M | 76.2 M | 56.9 M | 44.6 M | 25.4 M | 10.7 M | 11 M | 1.53 M | -11.4 M | -26.2 M |
Total Assets |
3.49 B | 3.44 B | 3.43 B | 3.49 B | 3.44 B | 3.43 B | 3.31 B | 3.33 B | 3.32 B | 3.31 B | 3.35 B | 3.34 B | 3.33 B | 3.35 B | 3.35 B | 3.75 B | 3.68 B | - | 3.67 B | 3.66 B | 3.68 B | 3.56 B | 3.43 B | 3.47 B | 3.43 B | 3.45 B | 3.51 B | 3.46 B | 3.46 B | 3.46 B | 3.44 B | 3.67 B | 3.7 B | 3.77 B | 3.76 B | 3.9 B | 3.9 B | 3.9 B | 3.91 B | 2.81 B | 2.83 B | 2.88 B | 2.95 B | 2.64 B | 2.63 B | 2.64 B | 2.64 B | 2.68 B | 2.73 B | 1.85 B | 1.8 B | 1.86 B | 1.81 B | 1.74 B | 1.74 B | 1.73 B | 1.79 B | 1.75 B | 1.76 B | 1.05 B | 1.06 B | 1.05 B | 1.06 B |
Cash and Cash Equivalents |
62.4 M | 119 M | 140 M | 62.4 M | 119 M | 140 M | 34.3 M | 50.9 M | 51.5 M | 34.3 M | 54.6 M | 63.6 M | 60.1 M | 54.6 M | 58.5 M | 86.4 M | 42.4 M | 35.9 M | 27.2 M | 21 M | 42.8 M | 164 M | 32.3 M | 62.1 M | 26.6 M | 57.9 M | 94.8 M | 28.6 M | 27.9 M | 29 M | 27.5 M | 24.7 M | 36.9 M | 34.3 M | 32.5 M | 45.4 M | 43 M | 44.1 M | 41.9 M | 63.3 M | 30.5 M | 28.9 M | 27.2 M | 49 M | 22.2 M | 21.6 M | 21.3 M | 22 M | 21.7 M | 15.7 M | 28.3 M | 94.4 M | 26.8 M | 19.3 M | 15.7 M | 10.4 M | 29 M | 4.4 M | 19 M | 4.44 M | 7.96 M | 5.99 M | 13.3 M |
Book Value |
1.83 B | 1.82 B | 1.86 B | 1.83 B | 1.82 B | 1.86 B | 1.68 B | 1.79 B | 1.73 B | 1.68 B | 1.48 B | 1.6 B | 1.54 B | 1.48 B | 1.45 B | 1.69 B | 1.62 B | - | 1.58 B | 1.52 B | 1.46 B | 1.42 B | 1.36 B | 1.32 B | 1.28 B | 1.23 B | 1.17 B | 1.16 B | 1.11 B | 1.1 B | 1.1 B | 1.23 B | 1.19 B | 1.16 B | 1.18 B | 1.22 B | 896 M | 859 M | 823 M | 800 M | 775 M | 737 M | 744 M | 721 M | 686 M | 663 M | 628 M | 609 M | 594 M | 586 M | 563 M | 544 M | 541 M | 500 M | 478 M | 457 M | 439 M | 418 M | 403 M | 402 M | 391 M | 378 M | 362 M |
Total Shareholders Equity |
1.83 B | 1.82 B | 1.86 B | 1.83 B | 1.82 B | 1.86 B | 1.68 B | 1.79 B | 1.73 B | 1.68 B | 1.48 B | 1.6 B | 1.54 B | 1.48 B | 1.45 B | 1.69 B | 1.62 B | 1.58 B | 1.58 B | 1.52 B | 1.46 B | 1.42 B | 1.42 B | 1.32 B | 1.32 B | 1.28 B | 1.17 B | 1.16 B | 1.16 B | 1.11 B | 1.1 B | 1.23 B | 1.23 B | 1.19 B | 1.18 B | 1.22 B | 896 M | 859 M | 823 M | 800 M | 775 M | 737 M | 744 M | 721 M | 686 M | 663 M | 628 M | 609 M | 594 M | 586 M | 563 M | 544 M | 541 M | 500 M | 478 M | 457 M | 439 M | 418 M | 403 M | 402 M | 391 M | 378 M | 362 M |
All numbers in USD currency
Balance Sheet is a fundamental financial report of Prestige Consumer Healthcare , providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
Balance sheet of other industry stocks – Medical distribution
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
AmerisourceBergen Corporation
ABC
|
- | -0.23 % | $ 37.5 B |  USA |
 |
PPD, Inc.
PPD
|
- | 0.13 % | $ 16.6 B | USA |
 |
Owens & Minor
OMI
|
- | - | $ 215 M | USA |
 |
Patterson Companies
PDCO
|
- | -0.87 % | $ 3 B | USA |
 |
Henry Schein
HSIC
|
$ 85.83 | 0.14 % | $ 10.4 B | USA |
 |
Cardinal Health
CAH
|
$ 229.12 | -1.46 % | $ 55.2 B | USA |
 |
McKesson Corporation
MCK
|
$ 888.56 | -0.11 % | $ 143 B | USA |